Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 18 Billion | USD 79 Billion | 15% | 2021 |
FrequentlyAsked Questions
The global bioprocess technology market is projected to register higher growth in the coming years due to the extensive use of these technologies in two of the fastest-growing industries that are the food sector and pharmaceutical sector.
According to Zion Market Research, the global bioprocess technology market size was worth over USD 18 billion in 2021 and is predicted to grow to around USD $79 billion by 2028 with a compound annual growth rate (CAGR) of roughly 15% between 2022 and 2028.
The global bioprocess technology market was dominated by North America in 2021 and is anticipated to follow the same trend owing to the increased geriatric population along with the presence of many bioprocess technology manufacturers in regions like the USA and Canada.
The global bioprocess technology market is driven by players like Lonza, GE Healthcare (General Electric Company), Thermo Fisher Scientific, IncSartorius AG, Eppendorf AG, Dickinson and Company, Becton, Siemens Healthineers, Nova Biomedical, Advanced Instruments, F. Hoffmann-La Roche Ltd., and Danaher Corporation.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed